Jame Abraham Selected Research

Jame Abraham Research Topics

Disease

56	Breast Neoplasms (Breast Cancer) 10/2022 - 10/2004
42	Neoplasms (Cancer) 10/2022 - 02/2003
6	Neoplasm Metastasis (Metastasis) 04/2020 - 02/2003
4	Disease Progression 01/2022 - 08/2008
4	Diarrhea 12/2019 - 05/2002
3	Fatigue 10/2019 - 05/2002
3	Cognitive Dysfunction 08/2011 - 12/2007
3	Neutropenia 05/2009 - 05/2003
2	Weight Loss (Weight Reduction) 01/2022 - 10/2015
2	Body Weight (Weight, Body) 01/2022 - 01/2019
2	Obesity 01/2022 - 10/2015
2	Pathologic Complete Response 12/2019 - 01/2016
2	Nausea 10/2019 - 05/2002
2	Thrombocytopenia (Thrombopenia) 10/2019 - 01/2016
2	Dehydration (Water Stress) 10/2019 - 12/2013
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2017
2	Alopecia (Baldness) 01/2018 - 01/2017
2	Triple Negative Breast Neoplasms 01/2017 - 10/2015
2	Melanoma (Melanoma, Malignant) 02/2014 - 02/2014
2	Circulating Neoplastic Cells 06/2010 - 08/2008
2	Adrenocortical Carcinoma 02/2003 - 05/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Prostatic Neoplasms (Prostate Cancer) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Heart Diseases (Heart Disease) 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Dyspareunia 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Dysuria 01/2019
1	Necrosis 01/2019
1	Pruritus (Itching) 01/2019
1	Retinoblastoma (Glioblastoma, Retinal) 12/2017

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 01/2022 - 05/2008
8	Trastuzumab (Herceptin)FDA Link 10/2020 - 09/2007
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2007
5	neratinibIBA 01/2020 - 12/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2015
4	Estrogen ReceptorsIBA 10/2021 - 04/2007
4	Estrogens (Estrogen)FDA Link 10/2021 - 08/2011
4	human ERBB2 proteinIBA 10/2020 - 01/2019
4	pertuzumabIBA 10/2020 - 03/2014
4	taxaneIBA 10/2019 - 05/2008
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 12/2017
3	Aromatase InhibitorsIBA 01/2021 - 08/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 10/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 05/2002
3	ixabepilone (BMS 247550)FDA Link 03/2013 - 05/2003
3	Pharmaceutical PreparationsIBA 03/2010 - 02/2003
2	ElectrolytesIBA 10/2019 - 12/2013
2	palbociclibIBA 07/2019 - 08/2018
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019 - 08/2018
2	Lapatinib (GW572016)FDA Link 01/2019 - 09/2007
2	Epidermal Growth Factor (EGF)IBA 11/2018 - 01/2017
2	Bevacizumab (Avastin)FDA Link 01/2017 - 07/2009
2	Carboplatin (JM8)FDA LinkGeneric 03/2016 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2016 - 03/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2011 - 04/2007
2	Vinorelbine (Navelbine)FDA LinkGeneric 05/2009 - 02/2003
2	tariquidar (XR9576)IBA 05/2009 - 02/2003
2	Vincristine (Oncovin)FDA LinkGeneric 10/2008 - 05/2002
2	Tumor Biomarkers (Tumor Markers)IBA 08/2008 - 06/2008
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Everolimus FDA Link 01/2022
1	exemestane (Aromasin)FDA Link 01/2022
1	SteroidsIBA 10/2021
1	Androstenedione (4 Androstene 3,17 dione)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020
1	CreatinineIBA 12/2020
1	Ado-Trastuzumab EmtansineIBA 10/2020
1	AntibodiesIBA 10/2020
1	trastuzumab deruxtecanIBA 10/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Immunoconjugates (Immunoconjugate)IBA 10/2020
1	Transaminases (Aminotransferases)IBA 10/2019
1	Letrozole (Femara)FDA LinkGeneric 07/2019
1	Fulvestrant (Faslodex)FDA Link 07/2019
1	Dietary Fats (Dietary Fat)IBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Biological FactorsIBA 01/2019
1	abemaciclibIBA 08/2018
1	ribociclibIBA 08/2018
1	Diphosphonates (Bisphosphonates)IBA 05/2018
1	Cyclin D1IBA 12/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	AnthracyclinesIBA 01/2017

Therapy/Procedure

41	Therapeutics 01/2022 - 01/2003
20	Drug Therapy (Chemotherapy) 10/2022 - 09/2003
5	Neoadjuvant Therapy 01/2019 - 03/2014
5	Adjuvant Chemotherapy 10/2014 - 03/2006
3	Time-to-Treatment 01/2021 - 01/2019
2	Investigational Therapies (Experimental Therapy) 04/2020 - 11/2007
2	Combination Drug Therapy (Combination Chemotherapy) 10/2008 - 05/2002
2	Stem Cell Transplantation 01/2003 - 01/2003
1	Bariatric Surgery 01/2022
1	Radiotherapy 01/2022
1	Shared Medical Appointments 01/2019
1	Mastectomy (Mammectomy) 12/2017
1	Protective Devices (Safety Device) 01/2017